Lindsey C. Aschenbach

Design, Synthesis, and Biological Evaluation of 6α- and 6β-<i>N</i>-Heterocyclic Substituted Naltrexamine Derivatives as μ Opioid Receptor Selective Antagonists

Li Guo, Lindsey C. Aschenbach, Jianyang Chen et al. · Journal of Medicinal Chemistry · 2009 · 86 citations · Full text

Design, Synthesis, and Biological Evaluation of 14-Heteroaromatic-Substituted Naltrexone Derivatives: Pharmacological Profile Switch from Mu Opioid Receptor Selectivity to Mu/Kappa Opioid Receptor Dual Selectivity

Yunyun Yuan, Saheem A. Zaidi, Orgil Elbegdorj et al. · Journal of Medicinal Chemistry · 2013 · 41 citations · Full text

Synthesis, Structural Reassignment, and Biological Activity of Type B MAO Inhibitors Based on the 5<i>H</i>-Indeno[1,2-<i>c</i>]pyridazin-5-one Core

Raphaël Frédérick, Willy Dumont, Frédéric Ooms et al. · Journal of Medicinal Chemistry · 2006 · 38 citations · Full text

Combinatorial Chemistry, Bioorganic Chemistry, Enzyme Inhibitor Properties +17

Prostaglandin E2 Receptors Are Differentially Expressed in Subpopulations of Granulosa Cells from Primate Periovulatory Follicles1

Siabhon M. Harris, Lindsey C. Aschenbach, Stephanie M. Skinner et al. · Biology of Reproduction · 2011 · 30 citations · Full text

Fertility, Immunology, Female Reproductive Function +25

14-O-Heterocyclic-substituted naltrexone derivatives as non-peptide mu opioid receptor selective antagonists: Design, synthesis, and biological studies

Li Guo, Lindsey C. Aschenbach, Hengjun He et al. · Bioorganic & Medicinal Chemistry Letters · 2008 · 21 citations · Full text

14-O-heterocyclic-substituted Naltrexone Derivatives, Molecular Pharmacology, Medicine +9